These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3598760)

  • 1. Effect of methylphenidate on skin conductance in hyperactive children and its relationship to urinary peptides.
    Mørkrid L; Qiao ZG; Reichelt KL
    J Oslo City Hosp; 1987 Apr; 37(4):35-40. PubMed ID: 3598760
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of methylphenidate on response inhibition and the event-related potential of children with attention deficit/hyperactivity disorder.
    Broyd SJ; Johnstone SJ; Barry RJ; Clarke AR; McCarthy R; Selikowitz M; Lawrence CA
    Int J Psychophysiol; 2005 Oct; 58(1):47-58. PubMed ID: 15925419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hyperactive child.
    Chapel JL
    Mo Med; 1973 Nov; 70(11):768-74. PubMed ID: 4753031
    [No Abstract]   [Full Text] [Related]  

  • 5. Attention deficit hyperactivity disorder, infantile autism, and elevated blood-lead: a possible relationship.
    Eppright TD; Sanfacon JA; Horwitz EA
    Mo Med; 1996 Mar; 93(3):136-8. PubMed ID: 8867271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention deficit disorders: a study of peptide-containing urinary complexes.
    Hole K; Lingjaerde O; Mørkrid L; Bøler JB; Saelid G; Diderichsen J; Ruud E; Reichelt KL
    J Dev Behav Pediatr; 1988 Aug; 9(4):205-12. PubMed ID: 3216000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.
    Posey DJ; Aman MG; McCracken JT; Scahill L; Tierney E; Arnold LE; Vitiello B; Chuang SZ; Davies M; Ramadan Y; Witwer AN; Swiezy NB; Cronin P; Shah B; Carroll DH; Young C; Wheeler C; McDougle CJ
    Biol Psychiatry; 2007 Feb; 61(4):538-44. PubMed ID: 17276750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
    Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
    Yang P; Hsu HY; Chiou SS; Chao MC
    Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing attention-deficit/hyperactivity disorder in children.
    Greenhill LL
    J Clin Psychiatry; 1998; 59 Suppl 7():31-41. PubMed ID: 9680051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential evaluation of behavioral treatments and methylphenidate dosage for children with attention deficit hyperactivity disorder.
    Gulley V; Northup J; Hupp S; Spera S; LeVelle J; Ridgway A
    J Appl Behav Anal; 2003; 36(3):375-8. PubMed ID: 14596580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional and longitudinal study of age effects of electrophysiological measures in hyperactive and normal children.
    Satterfield JH; Schell AM; Backs RW; Hidaka KC
    Biol Psychiatry; 1984 Jul; 19(7):973-90. PubMed ID: 6332646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention deficit disorder in children: three clinical variants.
    de Quirós GB; Kinsbourne M; Palmer RL; Rufo DT
    J Dev Behav Pediatr; 1994 Oct; 15(5):311-9. PubMed ID: 7868698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention deficit or lack of attention?
    Bird S; Emond A
    Arch Dis Child Educ Pract Ed; 2007 Jun; 92(3):ep76-81. PubMed ID: 17517976
    [No Abstract]   [Full Text] [Related]  

  • 17. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment.
    Gadow KD; Nolan E; Sprafkin J; Sverd J
    J Dev Behav Pediatr; 1995 Jun; 16(3):167-76. PubMed ID: 7560119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylphenidate use for attention deficit hyperactivity disorder in northern Israel--a controversial issue.
    Fogelman Y; Kahan E
    Isr Med Assoc J; 2001 Dec; 3(12):925-7. PubMed ID: 11794916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Attention deficit hyperactivity disorder].
    Yamazaki K
    Seishin Shinkeigaku Zasshi; 2002; 104(1):55-65. PubMed ID: 11928313
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of actigraphy in the clinical setting: use in children with attention-deficit hyperactivity disorder.
    Miller LG; Kraft IA
    Pharmacotherapy; 1994; 14(2):219-23. PubMed ID: 8197043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.